Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease

Daniel Paris(Swiss Tropical and Public Health Institute), Michael Mullan(Roskamp Institute)
Journal of Neuroinflammation
January 1, 2010
10.1186/1742-2094-7-17
Cited by 165

Related Papers

Distinct Signaling Pathways Regulate TREM2 Phagocytic and NFκB Antagonistic Activities
|Frontiers in Cellular Neuroscience|2019|111
Amelioration of Experimental Autoimmune Encephalomyelitis by Anatabine
|PLoS ONE|2013|41
Chronic Anatabine Treatment Reduces Alzheimer’s Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD
|PLoS ONE|2015|35